NASDAQ · HSCS
Healthcare · Medical - Devices
$4.73
Down-$0.30 (-6.34%)
Updated Sep 28, 2026, 10:48 PM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · HSCS
1M range · 19 trading sessions · Daily adjusted prices
Prices through Sep 25, 2026
HSCS closed at $4.73 after 19 trading sessions, up 50.16% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.78 | $4.9999 | $4.66 | $4.73 | 97.96K |
| Sep 24, 2026 | $4.64 | $4.75 | $4.2302 | $4.63 | 126.05K |
| Sep 23, 2026 | $4.56 | $5.03 | $4.45 | $4.52 | 179.84K |
| Sep 22, 2026 | $4.76 | $5.21 | $4.5501 | $4.61 | 264.4K |
| Sep 21, 2026 | $5.25 | $5.25 | $4.62 | $4.68 | 247.53K |
| Sep 18, 2026 | $4.79 | $5.21 | $4.68 | $5.20 | 174.66K |
| Sep 17, 2026 | $3.90 | $4.89 | $3.8053 | $4.84 | 388.3K |
| Sep 16, 2026 | $3.45 | $3.94 | $3.4301 | $3.79 | 91.72K |
| Sep 15, 2026 | $3.50 | $3.50 | $3.25 | $3.44 | 65.67K |
| Sep 14, 2026 | $3.39 | $3.60 | $3.3302 | $3.54 | 81.06K |
| Sep 11, 2026 | $3.40 | $3.69 | $3.31 | $3.39 | 100.7K |
| Sep 10, 2026 | $3.86 | $4.015 | $3.38 | $3.51 | 227.96K |
| Sep 9, 2026 | $4.31 | $4.32 | $3.88 | $4.12 | 125.96K |
| Sep 8, 2026 | $3.98 | $4.35 | $3.905 | $4.08 | 289.24K |
| Sep 4, 2026 | $3.34 | $3.83 | $3.21 | $3.73 | 182.89K |
| Sep 3, 2026 | $3.12 | $3.45 | $2.96 | $3.36 | 178.29K |
| Sep 2, 2026 | $3.12 | $3.1891 | $3.00 | $3.01 | 25.41K |
| Sep 1, 2026 | $3.19 | $3.28 | $3.095 | $3.12 | 69.72K |
| Aug 31, 2026 | $3.01 | $3.20 | $2.95 | $3.15 | 56.05K |
The latest Smart Investors Daily articles mentioning HSCS.
HSCS research
Company profile and research snapshot.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 24, 2026 | Ascendiant Capital | Buy | — |
| Dec 22, 2025 | Ascendiant Capital | Buy | — |
| Oct 1, 2025 | Ascendiant Capital | Buy | — |
| Mar 18, 2025 | Ascendiant Capital | Buy | — |
| Dec 18, 2024 | Maxim Group | Buy | — |
No generated briefing is available yet.
Benzinga · Sep 14, 2026
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.86) per share. This is a 45.57 percent increase over losses of $(1.58) per share from the same period last year. The company reported $2.100
Benzinga · Aug 21, 2026
Gainers Picard Medical (AMEX:PMI) stock rose 40.2% to $4.5 during Friday's after-market session. The company's market cap stands at $6.2 million. As per the news, the Q2 earnings report came out 2 days ago.
Yahoo · Jul 29, 2026
Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company’s shareholders Fiscal 2026 saw the full commercial launch of the MyoVista Insights platform and submission of the MyoVista wavECG device to the FDA for 510(k) clearance Southlake, TX, July 29, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on a
Yahoo · Jul 28, 2026
The Digital Currency Group-owned Zcash miner brought its first greenfield site online as it looks to lower mining costs and advance plans to become a public company.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning HSCS.
